{"title":"急性冠状动脉综合征高危出血患者的临床和冠状动脉病变特征及预后。","authors":"Nobuaki Kobayashi, Yusaku Shibata, Osamu Kurihara, Shota Shigihara, Tomofumi Sawatani, Akihiro Shirakabe, Masamichi Takano, Kuniya Asai","doi":"10.1159/000547565","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although it is well-known that patients with high bleeding risk (HBR) who undergo percutaneous coronary intervention (PCI) have poor clinical outcomes, the details have not been fully clarified for acute coronary syndrome (ACS) population. The aim of this study was to describe patient and lesion characteristics in patients with ACS and HBR as defined by the Academic Research Consortium (ARC).</p><p><strong>Methods: </strong>Patients with ACS (n=961) who underwent optical coherence tomography (OCT)-guided PCI were investigated. They were divided into HBR and non-HBR groups according to the ARC HBR criteria. Clinical background, lesion characteristics on angiography and OCT, and clinical outcomes during the two-year follow-up period were compared between the groups.</p><p><strong>Results: </strong>The HBR group comprised 307 patients (32%). The frequency of multi-vessel coronary disease was higher in the HBR group than the non-HBR group (34% vs. 26%, p=0.015). OCT findings demonstrated a higher frequency of calcified nodules as the underlying pathology for ACS in the HBR group (12% vs. 3%, p<0.001), with a correspondingly higher frequency of calcified plaques (55% vs. 39%, p<0.001). Kaplan-Meier estimates of the incidence of major bleeding (11.0% vs. 2.4%, p<0.001) and cardiac death (8.5% vs. 2.4%, p<0.001) were more prevalent for the HBR group than the non-HBR group during the follow-up period.</p><p><strong>Conclusion: </strong>ACS patients with HBR factors had more advanced atherosclerosis which contributed to a higher prevalence of cardiac death as well as major bleeding complications.</p>","PeriodicalId":17530,"journal":{"name":"Journal of Vascular Research","volume":" ","pages":"1-20"},"PeriodicalIF":1.8000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical and Coronary Artery Lesion Characteristics and Outcomes in Acute Coronary Syndrome Patients with High Bleeding Risk.\",\"authors\":\"Nobuaki Kobayashi, Yusaku Shibata, Osamu Kurihara, Shota Shigihara, Tomofumi Sawatani, Akihiro Shirakabe, Masamichi Takano, Kuniya Asai\",\"doi\":\"10.1159/000547565\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although it is well-known that patients with high bleeding risk (HBR) who undergo percutaneous coronary intervention (PCI) have poor clinical outcomes, the details have not been fully clarified for acute coronary syndrome (ACS) population. The aim of this study was to describe patient and lesion characteristics in patients with ACS and HBR as defined by the Academic Research Consortium (ARC).</p><p><strong>Methods: </strong>Patients with ACS (n=961) who underwent optical coherence tomography (OCT)-guided PCI were investigated. They were divided into HBR and non-HBR groups according to the ARC HBR criteria. Clinical background, lesion characteristics on angiography and OCT, and clinical outcomes during the two-year follow-up period were compared between the groups.</p><p><strong>Results: </strong>The HBR group comprised 307 patients (32%). The frequency of multi-vessel coronary disease was higher in the HBR group than the non-HBR group (34% vs. 26%, p=0.015). OCT findings demonstrated a higher frequency of calcified nodules as the underlying pathology for ACS in the HBR group (12% vs. 3%, p<0.001), with a correspondingly higher frequency of calcified plaques (55% vs. 39%, p<0.001). Kaplan-Meier estimates of the incidence of major bleeding (11.0% vs. 2.4%, p<0.001) and cardiac death (8.5% vs. 2.4%, p<0.001) were more prevalent for the HBR group than the non-HBR group during the follow-up period.</p><p><strong>Conclusion: </strong>ACS patients with HBR factors had more advanced atherosclerosis which contributed to a higher prevalence of cardiac death as well as major bleeding complications.</p>\",\"PeriodicalId\":17530,\"journal\":{\"name\":\"Journal of Vascular Research\",\"volume\":\" \",\"pages\":\"1-20\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-07-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Vascular Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000547565\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547565","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
背景:虽然众所周知,高出血风险(HBR)患者接受经皮冠状动脉介入治疗(PCI)的临床结果较差,但急性冠状动脉综合征(ACS)人群的细节尚未完全明确。本研究的目的是描述学术研究联盟(ARC)定义的ACS和HBR患者的患者和病变特征。方法:961例ACS患者行光学相干断层扫描(OCT)引导下的PCI。根据ARC HBR标准,他们被分为HBR组和非HBR组。比较两组患者的临床背景、血管造影和OCT的病变特征以及2年随访期间的临床结果。结果:HBR组307例(32%)。HBR组多支冠状动脉病变发生率高于非HBR组(34% vs. 26%, p=0.015)。OCT结果显示,在HBR组中,钙化结节作为ACS的基础病理的频率更高(12% vs. 3%)。结论:HBR因素的ACS患者有更晚期的动脉粥样硬化,这导致了更高的心源性死亡和主要出血并发症的发生率。
Clinical and Coronary Artery Lesion Characteristics and Outcomes in Acute Coronary Syndrome Patients with High Bleeding Risk.
Background: Although it is well-known that patients with high bleeding risk (HBR) who undergo percutaneous coronary intervention (PCI) have poor clinical outcomes, the details have not been fully clarified for acute coronary syndrome (ACS) population. The aim of this study was to describe patient and lesion characteristics in patients with ACS and HBR as defined by the Academic Research Consortium (ARC).
Methods: Patients with ACS (n=961) who underwent optical coherence tomography (OCT)-guided PCI were investigated. They were divided into HBR and non-HBR groups according to the ARC HBR criteria. Clinical background, lesion characteristics on angiography and OCT, and clinical outcomes during the two-year follow-up period were compared between the groups.
Results: The HBR group comprised 307 patients (32%). The frequency of multi-vessel coronary disease was higher in the HBR group than the non-HBR group (34% vs. 26%, p=0.015). OCT findings demonstrated a higher frequency of calcified nodules as the underlying pathology for ACS in the HBR group (12% vs. 3%, p<0.001), with a correspondingly higher frequency of calcified plaques (55% vs. 39%, p<0.001). Kaplan-Meier estimates of the incidence of major bleeding (11.0% vs. 2.4%, p<0.001) and cardiac death (8.5% vs. 2.4%, p<0.001) were more prevalent for the HBR group than the non-HBR group during the follow-up period.
Conclusion: ACS patients with HBR factors had more advanced atherosclerosis which contributed to a higher prevalence of cardiac death as well as major bleeding complications.
期刊介绍:
The ''Journal of Vascular Research'' publishes original articles and reviews of scientific excellence in vascular and microvascular biology, physiology and pathophysiology. The scope of the journal covers a broad spectrum of vascular and lymphatic research, including vascular structure, vascular function, haemodynamics, mechanics, cell signalling, intercellular communication, growth and differentiation. JVR''s ''Vascular Update'' series regularly presents state-of-the-art reviews on hot topics in vascular biology. Manuscript processing times are, consistent with stringent review, kept as short as possible due to electronic submission. All articles are published online first, ensuring rapid publication. The ''Journal of Vascular Research'' is the official journal of the European Society for Microcirculation. A biennial prize is awarded to the authors of the best paper published in the journal over the previous two years, thus encouraging young scientists working in the exciting field of vascular biology to publish their findings.